Stay updated on IMCgp100 vs Investigator Choice in Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the IMCgp100 vs Investigator Choice in Uveal Melanoma Clinical Trial page.

Latest updates to the IMCgp100 vs Investigator Choice in Uveal Melanoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page now shows recruitment has closed and includes new guidance sections to help readers understand the study record and enrollment process.SummaryDifference0.3%

- Check15 days agoChange DetectedThe page's revision version was updated from v3.5.4 to v3.5.5, signaling a small maintenance update to the page's content or metadata. It does not reflect changes to the study data or description.SummaryDifference0.0%

- Check23 days agoChange DetectedA new publication citation titled 'Five-Year Survival with Tebentafusp in Metastatic Uveal Melanoma' was added to the Publications section, referencing a 2026 Ann Oncol article related to the study. This links long-term survival data to the study record.SummaryDifference0.0%

- Check30 days agoChange DetectedRevision updated to v3.5.4, indicating a minor system update to the page rendering.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page now displays a new revision stamp, v3.5.3, replacing the previous v3.5.2, indicating a minor update to the page metadata rather than to the study content.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page revision/version label has been updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to IMCgp100 vs Investigator Choice in Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMCgp100 vs Investigator Choice in Uveal Melanoma Clinical Trial page.